Sociis, eget mollis, exercitationem fames mi porttitor per harum debitis! Praesent fugiat reprehenderit quia! Molestiae. Pellentesque. Quisque consequuntur, ante dis. Parturient mollit nostrum rhoncus
EPOS2020 will be the latest in the EPOS series of guidelines on rhinosinusitis from an international cohort of experts in the field and will build on the success of the previous EPOS papers.
The core objective of the EPOS2020 guideline is to provide real, practical, collaborative management strategies for rhinosinusitis based on a combination of evidence based and clinically relevant research. The aim is to build on the success of previous EPOS position papers, in particular EPOS2012, which was widely acclaimed for its presentation of science translated into clinical care and treatment of disease. EPOS2012 can also be credited with the sharp rise in understanding of separate endotypes in CRS and the relationship to different phenotypes. This knowledge will lead to significant adjustments in the management of CRS, especially in CRSwNP.
